Author

Francis Ince

Observed institutions: AstraZeneca (United Kingdom), Loughborough University

OpenAlex ID: A5110179764

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

2007 · Brian Springthorpe, Andrew Bailey, et al. · Bioorganic & Medicinal Chemistry Letters · 238

QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists

2003 · Rupert P. Austin, Patrick Barton, et al. · Journal of Medicinal Chemistry · 66

Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)- 4-hydroxybenzothiazol-2(3H)-one Analogues

1998 · Roger V. Bonnert, Roger C. Brown, et al. · Journal of Medicinal Chemistry · 51

3 The Medicinal Chemistry of the P2 Receptor Family

2001 · Simon D. Guile, Francis Ince, et al. · Progress in medicinal chemistry · 25

Novel Cobalt Complex Inhibitors of Mitochondrial Calcium Uptake

1999 · John F Unitt, Kerry L Boden, et al. · Bioorganic & Medicinal Chemistry · 22

A Mild and Convenient High-Yield Alternative to the Protic Acid Catalysed Pictet-Spengler Synthesis of Tetrahydroisoquinolines

1991 · Gi K. Cheung, Martyn J. Earle, et al. · Synlett · 17

Works count: 6

Citation count: 419

H-index: 6

I10-index: 6